Literature DB >> 23909728

Decline of lactate in tumor tissue after ketogenic diet: in vivo microdialysis study in patients with head and neck cancer.

U Schroeder1, B Himpe, R Pries, R Vonthein, S Nitsch, B Wollenberg.   

Abstract

In head and neck squamous cell carcinoma (HNSCC) aerobic glycolysis is the key feature for energy supply of the tumor. Quantitative microdialysis (μD) offers an online method to measure parameters of the carbohydrate metabolism in vivo. The aim was to standardize a quantitative μD-study in patients with HNSCC and to prove if a ketogenic diet would differently influence the carbohydrate metabolism of the tumor tissue. Commercially available 100 kDa-CMA71-μD- catheters were implanted in tumor-free and in tumor tissue in patients with HNSCC for simultaneous measurements up to 5 days. The metabolic pattern and circadian rhythm of urea, glucose, lactate, and pyruvate was monitored during 24 h of western diet and subsequent up to 4 days of ketogenic diet. After 3 days of ketogenic diet the mean lactate concentration declines to a greater extent in the tumor tissue than in the tumor-free mucosa, whereas the mean glucose and pyruvate concentrations rise. The in vivo glucose metabolism of the tumor tissue is clearly influenced by nutrition. The decline of mean lactate concentration in the tumor tissue after ketogenic diet supports the hypothesis that HNSCC tumor cells might use lactate as fuel for oxidative glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909728     DOI: 10.1080/01635581.2013.804579

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  19 in total

Review 1.  The Tumor Metabolic Microenvironment: Lessons from Lactate.

Authors:  Juan C García-Cañaveras; Li Chen; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2019-06-06       Impact factor: 12.701

Review 2.  A Review on Microdialysis Calibration Methods: the Theory and Current Related Efforts.

Authors:  Chun Min Kho; Siti Kartini Enche Ab Rahim; Zainal Arifin Ahmad; Norazharuddin Shah Abdullah
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

3.  [Efficacy of a ketogenic diet in urological cancers patients : A systematic review].

Authors:  P Maisch; J E Gschwend; M Retz
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

Review 4.  Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.

Authors:  Rainer J Klement
Journal:  Med Oncol       Date:  2017-06-26       Impact factor: 3.064

Review 5.  Systematic review: isocaloric ketogenic dietary regimes for cancer patients.

Authors:  N Erickson; A Boscheri; B Linke; J Huebner
Journal:  Med Oncol       Date:  2017-03-28       Impact factor: 3.064

6.  Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology.

Authors:  Zaheed Husain; Pankaj Seth; Vikas P Sukhatme
Journal:  Oncoimmunology       Date:  2013-10-09       Impact factor: 8.110

7.  Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?

Authors:  Martin Grimm; Marcel Cetindis; Max Lehmann; Thorsten Biegner; Adelheid Munz; Peter Teriete; Wiebke Kraut; Siegmar Reinert
Journal:  J Transl Med       Date:  2014-07-21       Impact factor: 5.531

Review 8.  Restricting carbohydrates to fight head and neck cancer-is this realistic?

Authors:  Rainer J Klement
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

Review 9.  Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.

Authors:  R J Klement; M K Fink
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

Review 10.  Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

Authors:  Ebbe Boedtkjer
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.